Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Non-Current Liabilities: 2018-2024

Historic Total Non-Current Liabilities for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $162.7 million.

  • Bicycle Therapeutics' Total Non-Current Liabilities fell 9.62% to $144.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.4 million, marking a year-over-year decrease of 9.62%. This contributed to the annual value of $162.7 million for FY2024, which is 26.00% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Total Non-Current Liabilities stood at $162.7 million for FY2024, which was down 26.00% from $219.8 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Total Non-Current Liabilities registered a high of $219.8 million during FY2023, and its lowest value of $63.1 million during FY2020.
  • Over the past 3 years, Bicycle Therapeutics' median Total Non-Current Liabilities value was $162.7 million (recorded in 2024), while the average stood at $172.8 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Total Non-Current Liabilities spiked by 320.51% in 2020 and then declined by 26.00% in 2024.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Total Non-Current Liabilities stood at $63.1 million in 2020, then skyrocketed by 106.49% to $130.3 million in 2021, then rose by 4.41% to $136.0 million in 2022, then surged by 61.65% to $219.8 million in 2023, then decreased by 26.00% to $162.7 million in 2024.